tiprankstipranks
Advertisement
Advertisement

KDA Group Names New CEO and Moves to Consolidate Key Healthcare Tech Subsidiary

Story Highlights
  • KDA Group named Jean-Marc Léveillé president and interim CEO, succeeding founder Marc Lemieux.
  • KDA plans to acquire ERxpert’s 20% stake in subsidiary GTK, consolidating control pending TSXV approval.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
KDA Group Names New CEO and Moves to Consolidate Key Healthcare Tech Subsidiary

Meet Samuel – Your Personal Investing Prophet

KDA Group Inc. ( (TSE:KDA) ) has issued an announcement.

KDA Group Inc., a Quebec-based provider of healthcare-focused SaaS and digital solutions for pharmaceutical and medical stakeholders, is positioning its technology to accelerate healthcare’s digital transformation in Canada and abroad. The company is recognized for its specialized software offerings designed to serve healthcare professionals in both domestic and international markets.

KDA has appointed Jean-Marc Léveillé as President, interim Chief Executive Officer, and Chairman, succeeding founder Marc Lemieux, who will remain a director until the next shareholders’ meeting. Léveillé’s mandate is to steer KDA from product development to large-scale commercialization, while the company also moves to consolidate full ownership of its key subsidiary GTK by acquiring ERxpert Inc.’s 20% stake, pending final TSX Venture Exchange approval.

With Léveillé’s background in organizational transformation, governance, and strategic talent management across naval, aerospace, and healthcare-related sectors, KDA aims to strengthen execution and performance in its scale-up phase. The planned share-based acquisition of the remaining GTK interest underscores KDA’s commitment to integrating its core healthcare technology operations and could simplify governance and strategic alignment for future growth.

More about KDA Group Inc.

KDA Group Inc. is a Quebec-based provider of technological innovations and specialized SaaS software solutions for healthcare professionals. Its high-quality products support the digital transformation of healthcare and are marketed to stakeholders across the pharmaceutical and medical sectors in Canada and international markets.

Average Trading Volume: 112,665

Technical Sentiment Signal: Sell

Current Market Cap: C$31.01M

For a thorough assessment of KDA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1